{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:33:05Z","timestamp":1789979585648,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T00:00:00Z","timestamp":1413158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/npp.2014.272","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T06:55:45Z","timestamp":1413183345000},"page":"957-965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures"],"prefix":"10.1038","volume":"40","author":[{"given":"Marta","family":"Peci\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S","family":"Stohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon-Kar","family":"Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,13]]},"reference":[{"key":"BFnpp2014272_CR1","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1152\/physrev.00043.2012","volume":"93","author":"F Benedetti","year":"2013","unstructured":"Benedetti F (2013). Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 93: 1207\u20131246.","journal-title":"Physiol Rev"},{"key":"BFnpp2014272_CR2","doi-asserted-by":"publisher","first-page":"10390","DOI":"10.1523\/JNEUROSCI.3458-05.2005","volume":"25","author":"F Benedetti","year":"2005","unstructured":"Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005). Neurobiological mechanisms of the placebo effect. J Neurosci 25: 10390\u201310402.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","volume":"28","author":"KC Berridge","year":"1998","unstructured":"Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309\u2013369.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp2014272_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0304-3959(00)00406-1","volume":"90","author":"T Bisgaard","year":"2001","unstructured":"Bisgaard T, Klarskov B, Rosenberg J, Kehlet H (2001). Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 90: 261\u2013269.","journal-title":"Pain"},{"key":"BFnpp2014272_CR5","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95: 9608\u20139613.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2014272_CR6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1467-6494.2004.00292.x","volume":"72","author":"T Canli","year":"2004","unstructured":"Canli T (2004). Functional brain mapping of extraversion and neuroticism: learning from individual differences in emotion processing. J Pers 72: 1105\u20131132.","journal-title":"J Pers"},{"key":"BFnpp2014272_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00000542-200608000-00016","volume":"105","author":"WY Chou","year":"2006","unstructured":"Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B (2006a). Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 105: 334\u2013337.","journal-title":"Anesthesiology"},{"key":"BFnpp2014272_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1399-6576.2006.01058.x","volume":"50","author":"WY Chou","year":"2006","unstructured":"Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH et al (2006b). Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 50: 787\u2013792.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BFnpp2014272_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1037\/0022-3514.38.4.668","volume":"38","author":"PT Costa Jr.","year":"1980","unstructured":"Costa PT Jr., McCrae RR (1980). Influence of extraversion and neuroticism on subjective well-being: happy and unhappy people. J Pers Soc Psychol 38: 668\u2013678.","journal-title":"J Pers Soc Psychol"},{"key":"BFnpp2014272_CR10","volume-title":"Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory Professional Manual","author":"PT Costa","year":"1992","unstructured":"Costa PT, McCrae RR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory Professional Manual. Psychological Assessment Resources: Odessa, FL."},{"key":"BFnpp2014272_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/hbm.460010306","volume":"1","author":"KJ Friston","year":"1994","unstructured":"Friston KJ, Worsley KJ, Frackowiak RS, Mazziotta JC, Evans AC (1994). Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1: 210\u2013220.","journal-title":"Hum Brain Mapp"},{"key":"BFnpp2014272_CR12","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1523\/JNEUROSCI.19-16-07175.1999","volume":"19","author":"RW Gear","year":"1999","unstructured":"Gear RW, Aley KO, Levine JD (1999). Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19: 7175\u20137181.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pain.2003.11.005","volume":"107","author":"L Goubert","year":"2004","unstructured":"Goubert L, Crombez G, Van Damme S (2004). The role of neuroticism, pain catastrophizing and pain-related fear in vigilance to pain: a structural equations approach. Pain 107: 234\u2013241.","journal-title":"Pain"},{"key":"BFnpp2014272_CR14","doi-asserted-by":"publisher","first-page":"e48135","DOI":"10.1371\/journal.pone.0048135","volume":"7","author":"KT Hall","year":"2012","unstructured":"Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB et al (2012). Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS ONE 7: e48135.","journal-title":"PLoS ONE"},{"key":"BFnpp2014272_CR15","doi-asserted-by":"publisher","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","volume":"27","author":"RE Harris","year":"2007","unstructured":"Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK (2007). Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27: 10000\u201310006.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/alcalc\/agn032","volume":"43","author":"CA Hodgkinson","year":"2008","unstructured":"Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA et al (2008). Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43: 505\u2013515.","journal-title":"Alcohol Alcohol"},{"key":"BFnpp2014272_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0306-4522(00)00019-1","volume":"96","author":"JC Horvitz","year":"2000","unstructured":"Horvitz JC (2000). Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96: 651\u2013656.","journal-title":"Neuroscience"},{"key":"BFnpp2014272_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/mp.2013.96","volume":"18","author":"DT Hsu","year":"2013","unstructured":"Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Wang H et al (2013). Response of the mu-opioid system to social rejection and acceptance. Mol Psychiatry 18: 1211\u20131217.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2014272_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483\u2013488.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/PSY.0b013e3181acee12","volume":"71","author":"JM Kelley","year":"2009","unstructured":"Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R et al (2009). Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med 71: 789\u2013797.","journal-title":"Psychosom Med"},{"key":"BFnpp2014272_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-4159.2007.04738.x","volume":"103","author":"T Kroslak","year":"2007","unstructured":"Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ (2007). The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 103: 77\u201387.","journal-title":"J Neurochem"},{"key":"BFnpp2014272_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.12.016","volume":"108","author":"SD Mague","year":"2010","unstructured":"Mague SD, Blendy JA (2010). OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 108: 172\u2013182.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2014272_CR23","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1073\/pnas.0901800106","volume":"106","author":"SD Mague","year":"2009","unstructured":"Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA (2009). Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci USA 106: 10847\u201310852.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2014272_CR24","volume-title":"EdITS Manual for the Profile of Mood States","author":"D McNair","year":"1992","unstructured":"McNair D, Lorr M, Droppleman I (1992) EdITS Manual for the Profile of Mood States. Educational and Industrial Testing Service (EdITS): San Diego."},{"key":"BFnpp2014272_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00000542-197101000-00017","volume":"34","author":"R Melzack","year":"1971","unstructured":"Melzack R, Torgerson WS (1971). On the language of pain. Anesthesiology 34: 50\u201359.","journal-title":"Anesthesiology"},{"key":"BFnpp2014272_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/syn.20566","volume":"62","author":"R Narendran","year":"2008","unstructured":"Narendran R, Martinez D (2008). Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse 62: 851\u2013869.","journal-title":"Synapse"},{"key":"BFnpp2014272_CR27","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nn1578","volume":"8","author":"EJ Nestler","year":"2005","unstructured":"Nestler EJ (2005). Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445\u20131449.","journal-title":"Nat Neurosci"},{"key":"BFnpp2014272_CR28","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1469-8986.2007.00551.x","volume":"44","author":"CJ Norris","year":"2007","unstructured":"Norris CJ, Larsen JT, Cacioppo JT (2007). Neuroticism is associated with larger and more prolonged electrodermal responses to emotionally evocative pictures. Psychophysiology 44: 823\u2013826.","journal-title":"Psychophysiology"},{"key":"BFnpp2014272_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.fpc.0000220566.90466.a2","volume":"16","author":"BG Oertel","year":"2006","unstructured":"Oertel BG, Schmidt R, Schneider A, Geisslinger G, Lotsch J (2006). The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet Genomics 16: 625\u2013636.","journal-title":"Pharmacogenet Genomics"},{"key":"BFnpp2014272_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1517\/14622416.5.8.1037","volume":"5","author":"G Oroszi","year":"2004","unstructured":"Oroszi G, Goldman D (2004). Alcoholism: genes and mechanisms. Pharmacogenomics 5: 1037\u20131048.","journal-title":"Pharmacogenomics"},{"key":"BFnpp2014272_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0163-1047(80)91077-8","volume":"30","author":"J Panksepp","year":"1980","unstructured":"Panksepp J, Beatty WW (1980). Social deprivation and play in rats. Behav Neural Biol 30: 197\u2013206.","journal-title":"Behav Neural Biol"},{"key":"BFnpp2014272_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/npp.2012.227","volume":"38","author":"M Pecina","year":"2012","unstructured":"Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS et al (2012a). Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology 38: 639\u2013646.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014272_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/npp.2012.227","volume":"38","author":"M Pecina","year":"2013","unstructured":"Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS et al (2013a). Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology 38: 639\u2013646.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014272_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/mp.2013.124","volume":"19","author":"M Pecina","year":"2014","unstructured":"Pecina M, Martinez-Jauand M, Hodgkinson C, Stohler CS, Goldman D, Zubieta JK (2014). FAAH selectively influences placebo effects. Mol Psychiatry 19: 385\u2013391.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2014272_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/mp.2012.16","volume":"18","author":"M Pecina","year":"2012","unstructured":"Pecina M, Stohler CS, Zubieta JK (2012b). Role of mu-opioid system in the formation of memory of placebo responses. Mol Psychiatry 18: 135\u2013137.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2014272_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/scan\/nst079","volume":"9","author":"M Pecina","year":"2013","unstructured":"Pecina M, Stohler CS, Zubieta JK (2013b). Neurobiology of placebo effects: expectations or learning? Soc Cogn Affect Neurosci 9: 1013\u20131021.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"BFnpp2014272_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1176\/appi.ajp.2010.09091348","volume":"167","author":"AR Prossin","year":"2010","unstructured":"Prossin AR, Love TM, Koeppe RA, Zubieta JK, Silk KR (2010). Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry 167: 925\u2013933.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2014272_CR38","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","volume":"24","author":"JC Pruessner","year":"2004","unstructured":"Pruessner JC, Champagne F, Meaney MJ, Dagher A (2004). Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 24: 2825\u20132831.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR39","doi-asserted-by":"publisher","first-page":"9268","DOI":"10.1073\/pnas.1018699108","volume":"108","author":"R Ray","year":"2011","unstructured":"Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C et al (2011). Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci USA 108: 9268\u20139273.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2014272_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuron.2007.06.028","volume":"55","author":"DJ Scott","year":"2007","unstructured":"Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2007). Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55: 325\u2013336.","journal-title":"Neuron"},{"key":"BFnpp2014272_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2007.34","volume":"65","author":"DJ Scott","year":"2008","unstructured":"Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65: 220\u2013231.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2014272_CR42","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1523\/JNEUROSCI.19-06-02347.1999","volume":"19","author":"Y Shoji","year":"1999","unstructured":"Shoji Y, Delfs J, Williams JT (1999). Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal. J Neurosci 19: 2347\u20132355.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/ALN.0b013e318182af21","volume":"109","author":"AT Sia","year":"2008","unstructured":"Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R et al (2008). A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 109: 520\u2013526.","journal-title":"Anesthesiology"},{"key":"BFnpp2014272_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3959(98)00171-7","volume":"79","author":"CS Stohler","year":"1999","unstructured":"Stohler CS, Kowalski CJ (1999). Spatial and temporal summation of sensory and affective dimensions of deep somatic pain. Pain 79: 165\u2013173.","journal-title":"Pain"},{"key":"BFnpp2014272_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1744-8069-5-32","volume":"5","author":"EC Tan","year":"2009","unstructured":"Tan EC, Lim EC, Teo YY, Lim Y, Law HY, Sia AT (2009). Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 5: 32.","journal-title":"Mol Pain"},{"key":"BFnpp2014272_CR46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.pain.2010.06.032","volume":"151","author":"KS Taylor","year":"2010","unstructured":"Taylor KS, Anastakis DJ, Davis KD (2010). Chronic pain and sensorimotor deficits following peripheral nerve injury. Pain 151: 582\u2013591.","journal-title":"Pain"},{"key":"BFnpp2014272_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2011.12.033","volume":"205","author":"YJ Wang","year":"2012","unstructured":"Wang YJ, Huang P, Ung A, Blendy JA, Liu-Chen LY (2012). Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G. Neuroscience 205: 178\u2013184.","journal-title":"Neuroscience"},{"key":"BFnpp2014272_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","volume":"54","author":"D Watson","year":"1988","unstructured":"Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063\u20131070.","journal-title":"J Pers Soc Psychol"},{"key":"BFnpp2014272_CR49","doi-asserted-by":"publisher","first-page":"15079","DOI":"10.1073\/pnas.0812612106","volume":"106","author":"BM Way","year":"2009","unstructured":"Way BM, Taylor SE, Eisenberger NI (2009). Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proc Natl Acad Sci USA 106: 15079\u201315084.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2014272_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/S146114571200017X","volume":"16","author":"EM Weerts","year":"2013","unstructured":"Weerts EM, McCaul ME, Kuwabara H, Yang X, Xu X, Dannals RF et al (2013). Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. Int J Neuropsychopharmacol 16: 47\u201353.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2014272_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/386499a0","volume":"386","author":"JE Zadina","year":"1997","unstructured":"Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997). A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386: 499\u2013502.","journal-title":"Nature"},{"key":"BFnpp2014272_CR52","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1523\/JNEUROSCI.4643-03.2004","volume":"24","author":"DH Zald","year":"2004","unstructured":"Zald DH, Boileau I, El-Dearedy W, Gunn R, McGlone F, Dichter GS et al (2004). Dopamine transmission in the human striatum during monetary reward tasks. J Neurosci 24: 4105\u20134112.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1109\/10.222327","volume":"40","author":"X Zhang","year":"1993","unstructured":"Zhang X, Ashton-Miller JA, Stohler CS (1993). A closed-loop system for maintaining constant experimental muscle pain in man. IEEE Trans Biomed Eng 40: 344\u2013352.","journal-title":"IEEE Trans Biomed Eng"},{"key":"BFnpp2014272_CR54","doi-asserted-by":"publisher","first-page":"32618","DOI":"10.1074\/jbc.M504942200","volume":"280","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W (2005). Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280: 32618\u201332624.","journal-title":"J Biol Chem"},{"key":"BFnpp2014272_CR55","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","volume":"25","author":"JK Zubieta","year":"2005","unstructured":"Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA et al (2005). Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25: 7754\u20137762.","journal-title":"J Neurosci"},{"key":"BFnpp2014272_CR56","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.1078546","volume":"299","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y et al (2003a). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299: 1240\u20131243.","journal-title":"Science"},{"key":"BFnpp2014272_CR57","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","volume":"60","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA et al (2003b). Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen psychiatry 60: 1145\u20131153.","journal-title":"Arch Gen psychiatry"},{"key":"BFnpp2014272_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1126\/science.1060952","volume":"293","author":"JK Zubieta","year":"2001","unstructured":"Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM et al (2001). Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293: 311\u2013315.","journal-title":"Science"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2014272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T17:12:55Z","timestamp":1717434775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2014272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,13]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFnpp2014272"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.272","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,13]]},"assertion":[{"value":"30 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}